Theranostics for Meningioma on the Rise: New EANM/EANO/RANO/SNMMI Guidelines Pave the Way to Improved Patient Outcomes Using Radiolabeled Somatostatin Receptor Ligands. Editorial Article uri icon

Overview

publication date

  • January 3, 2025

Identity

Scopus Document Identifier

  • 85213969820

Digital Object Identifier (DOI)

  • 10.2967/jnumed.124.268314

PubMed ID

  • 39389626

Additional Document Info

volume

  • 66

issue

  • 1